The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukoplakia, Oral

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukoplakia, Oral


Psychiatry related information on Leukoplakia, Oral


High impact information on Leukoplakia, Oral


Chemical compound and disease context of Leukoplakia, Oral


Biological context of Leukoplakia, Oral


Anatomical context of Leukoplakia, Oral


Gene context of Leukoplakia, Oral


Analytical, diagnostic and therapeutic context of Leukoplakia, Oral


  1. 13-cis-retinoic acid in the treatment of oral leukoplakia. Hong, W.K., Endicott, J., Itri, L.M., Doos, W., Batsakis, J.G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E.N., Vaughan, C. N. Engl. J. Med. (1986) [Pubmed]
  2. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Mutirangura, A., Supiyaphun, P., Trirekapan, S., Sriuranpong, V., Sakuntabhai, A., Yenrudi, S., Voravud, N. Cancer Res. (1996) [Pubmed]
  3. Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results. Chiesa, F., Tradati, N., Grigolato, R., Boracchi, P., Biganzoli, E., Crose, N., Cavadini, E., Formelli, F., Costa, L., Giardini, R., Zurrida, S., Costa, A., De Palo, G., Veronesi, U. Int. J. Cancer (2005) [Pubmed]
  4. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Srinivasan, M., Jewell, S.D. Oncology (2001) [Pubmed]
  5. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Chen, H.M., Yu, C.H., Tu, P.C., Yeh, C.Y., Tsai, T., Chiang, C.P. Lasers in surgery and medicine. (2005) [Pubmed]
  6. Oral-dental findings in dyskeratosis congenita. Yavuzyilmaz, E., Yamalik, N., Yetgin, S., Kansu, O. J. Oral Pathol. Med. (1992) [Pubmed]
  7. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Hu, L., Crowe, D.L., Rheinwald, J.G., Chambon, P., Gudas, L.J. Cancer Res. (1991) [Pubmed]
  8. Response of oral leukoplakia to beta-carotene. Garewal, H.S., Meyskens, F.L., Killen, D., Reeves, D., Kiersch, T.A., Elletson, H., Strosberg, A., King, D., Steinbronn, K. J. Clin. Oncol. (1990) [Pubmed]
  9. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Mulshine, J.L., Atkinson, J.C., Greer, R.O., Papadimitrakopoulou, V.A., Van Waes, C., Rudy, S., Martin, J.W., Steinberg, S.M., Liewehr, D.J., Avis, I., Linnoila, R.I., Hewitt, S., Lippman, S.M., Frye, R., Cavanaugh, P.F. Clin. Cancer Res. (2004) [Pubmed]
  10. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Singh, V.N., Gaby, S.K. Am. J. Clin. Nutr. (1991) [Pubmed]
  11. Expression of alpha(v)beta6 integrin in oral leukoplakia. Hamidi, S., Salo, T., Kainulainen, T., Epstein, J., Lerner, K., Larjava, H. Br. J. Cancer (2000) [Pubmed]
  12. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Kresty, L.A., Carmella, S.G., Borukhova, A., Akerkar, S.A., Gopalakrishnan, R., Harris, R.E., Stoner, G.D., Hecht, S.S. Cancer Epidemiol. Biomarkers Prev. (1996) [Pubmed]
  13. Cytologic and DNA-cytometric follow-up of oral leukoplakia after CO2- and Er:YAG-laser assisted ablation: a pilot study. Schwarz, F., Maraki, D., Yalcinkaya, S., Bieling, K., Böcking, A., Becker, J. Lasers in surgery and medicine. (2005) [Pubmed]
  14. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280). Majumder, M., Sikdar, N., Paul, R.R., Roy, B. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  15. Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma. Gao, S., Worm, J., Guldberg, P., Eiberg, H., Krogdahl, A., Sørensen, J.A., Liu, C.J., Reibel, J., Dabelsteen, E. Br. J. Cancer (2004) [Pubmed]
  16. Expression of p27 and apoptosis in oral leukoplakia. Tsuzuki, H., Fujieda, S., Sunaga, H., Narita, N., Tokuriki, M., Saito, H. Anticancer Res. (2003) [Pubmed]
  17. Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of beta-carotene or vitamin A. Stich, H.F., Mathew, B., Sankaranarayanan, R., Nair, M.K. Am. J. Clin. Nutr. (1991) [Pubmed]
  18. Telomerase activity in premalignant and malignant lesions of human oral mucosa. Kannan, S., Tahara, H., Yokozaki, H., Mathew, B., Nalinakumari, K.R., Nair, M.K., Tahara, E. Cancer Epidemiol. Biomarkers Prev. (1997) [Pubmed]
  19. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid. Beenken, S.W., Sellers, M.T., Huang, P., Peters, G., Krontiras, H., Dixon, P., Stockard, C., Listinsky, C., Grizzle, W.E. Head & neck. (1999) [Pubmed]
  20. Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis. Ries, J.C., Hassfurther, E., Steininger, H., Kloss, F.R., Wiltfang, J., Girod, S.C., Neukam, F.W. Anticancer Res. (2001) [Pubmed]
  21. Keratosis follicularis of the oral mucosa with oral squamous cell carcinoma. Dolci, M., Favia, G., Scully, C., Di Alberti, L. Oral Oncol. (2004) [Pubmed]
  22. Immunolocalization of p53, glutathione S-tranferase pi and CD57 antigens in oral leukoplakia. De Paula, A.M., Gomez, R.S. Anticancer Res. (2001) [Pubmed]
  23. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. Kurokawa, H., Matsumoto, S., Murata, T., Yamashita, Y., Tomoyose, T., Zhang, M., Fukuyama, H., Takahashi, T. J. Oral Pathol. Med. (2003) [Pubmed]
  24. GSTT1 polymorphism and oral leukoplakia. Barroso Duarte, E.C., Da Silva, M.S., Gomez, M.V., Gomez, R.S. Anticancer Res. (2006) [Pubmed]
  25. GSTM1 polymorphism and oral leukoplakia. Duarte, E.C., da Silva, M.S., Gomez, M.V., Gomez, R.S. J. Oral Pathol. Med. (2006) [Pubmed]
  26. Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas. Vigneswaran, N., Peters, K.P., Hornstein, O.P., Haneke, E. J. Oral Pathol. Med. (1989) [Pubmed]
  27. Emerging role of beta-carotene and antioxidant nutrients in prevention of oral cancer. Garewal, H.S., Schantz, S. Arch. Otolaryngol. Head Neck Surg. (1995) [Pubmed]
  28. Carbon dioxide laser surgery of oral leukoplakia. Roodenburg, J.L., Panders, A.K., Vermey, A. Oral Surg. Oral Med. Oral Pathol. (1991) [Pubmed]
  29. bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study. Piattelli, A., Fioroni, M., Santinelli, A., Rubini, C. Oral Oncol. (1999) [Pubmed]
  30. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity. Rajendran, R., Remani, P., Vijayakumar, T., Vasudevan, D.M. Annals of dentistry. (1990) [Pubmed]
WikiGenes - Universities